Clinical Trial Update: Gamma Induction for Alzheimer's Disease [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial update evaluating gamma induction as a potential therapy for Alzheimer's disease and mild cognitive impairment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Alzheimer Disease, Mild Cognitive Impairment | Phase 1, Phase 2 | Status: COMPLETED